# Nathans Famous, Inc.: financial statements, quarterly

NATH · Nasdaq · CIK 69733 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 28

Pages: [Overview](/companies/nath.md) · [Financials](/companies/nath/financials.md) · [Filings](/companies/nath/filings.md) · [Insiders](/companies/nath/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nath/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-09-24) | Q3 FY2023 (2023-12-24) | Q4 FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-29) | Q3 FY2024 (2024-12-29) | Q4 FY2024 (2025-03-30) | Q1 FY2025 (2025-06-29) | Q2 FY2025 (2025-09-28) | Q3 FY2025 (2025-12-28) | Q4 FY2025 (2026-03-29) | Q1 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [38.7](/filings/0001437749-24-033728.md) | [28.9](/filings/0001437749-25-002936.md) | [29.0 d](/filings/0001437749-25-019916.md) | [44.8](/filings/0001437749-25-025551.md) | [41.1](/filings/0001437749-25-033452.md) | [31.5](/filings/0001437749-26-003087.md) | [30.8 d](/filings/0001437749-26-019923.md) | [47.0](/filings/0001437749-26-026427.md) | [45.7](/filings/0001437749-25-033452.md) | [34.3](/filings/0001437749-26-003087.md) | [35.1 d](/filings/0001437749-26-019923.md) | [54.1](/filings/0001437749-26-026427.md) |
| Cost of revenue | $m | [24.2](/filings/0001437749-24-033728.md) | [17.9](/filings/0001437749-25-002936.md) | [16.4 d](/filings/0001437749-25-019916.md) | [25.2](/filings/0001437749-25-025551.md) | [26.0](/filings/0001437749-25-033452.md) | [19.6](/filings/0001437749-26-003087.md) | [18.9 d](/filings/0001437749-26-019923.md) | [28.4](/filings/0001437749-26-026427.md) | [32.4](/filings/0001437749-25-033452.md) | [23.1](/filings/0001437749-26-003087.md) | [22.6 d](/filings/0001437749-26-019923.md) | [35.2](/filings/0001437749-26-026427.md) |
| Gross profit | $m | not reported | not reported | not reported | [19.5](/filings/0001437749-25-025551.md) | [15.1](/filings/0001437749-25-033452.md) | [11.9](/filings/0001437749-26-003087.md) | [11.9 d](/filings/0001437749-26-019923.md) | [18.6](/filings/0001437749-26-026427.md) | [13.3](/filings/0001437749-25-033452.md) | [11.2](/filings/0001437749-26-003087.md) | [12.5 d](/filings/0001437749-26-019923.md) | [18.9](/filings/0001437749-26-026427.md) |
| Operating income | $m | [9.1](/filings/0001437749-24-033728.md) | [5.1](/filings/0001437749-25-002936.md) | [6.8 d](/filings/0001437749-25-019916.md) | [13.7](/filings/0001437749-25-025551.md) | [9.6](/filings/0001437749-25-033452.md) | [6.8](/filings/0001437749-26-003087.md) | [6.4 d](/filings/0001437749-26-019923.md) | [12.8](/filings/0001437749-26-026427.md) | [7.5](/filings/0001437749-25-033452.md) | [5.1](/filings/0001437749-26-003087.md) | [4.7 d](/filings/0001437749-26-019923.md) | [12.7](/filings/0001437749-26-026427.md) |
| Interest expense | $m | not reported | not reported | not reported | [1.1](/filings/0001437749-25-025551.md) | [1.4](/filings/0001437749-25-033452.md) | [0.8](/filings/0001437749-26-003087.md) | [0.8 d](/filings/0001437749-26-019923.md) | [0.8](/filings/0001437749-26-026427.md) | [0.7](/filings/0001437749-25-033452.md) | [0.7](/filings/0001437749-26-003087.md) | [0.7 d](/filings/0001437749-26-019923.md) | [0.6](/filings/0001437749-26-026427.md) |
| Income tax | $m | [2.2](/filings/0001437749-24-033728.md) | [1.1](/filings/0001437749-25-002936.md) | [1.8 d](/filings/0001437749-25-019916.md) | [3.5](/filings/0001437749-25-025551.md) | [2.1](/filings/0001437749-25-033452.md) | [1.6](/filings/0001437749-26-003087.md) | [1.6 d](/filings/0001437749-26-019923.md) | [3.3](/filings/0001437749-26-026427.md) | [1.8](/filings/0001437749-25-033452.md) | [1.7](/filings/0001437749-26-003087.md) | [1.4 d](/filings/0001437749-26-019923.md) | [3.3](/filings/0001437749-26-026427.md) |
| Net income | $m | [5.7](/filings/0001437749-24-033728.md) | [2.6](/filings/0001437749-25-002936.md) | [3.9 d](/filings/0001437749-25-019916.md) | [9.3](/filings/0001437749-25-025551.md) | [6.0](/filings/0001437749-25-033452.md) | [4.5](/filings/0001437749-26-003087.md) | [4.2 d](/filings/0001437749-26-019923.md) | [8.9](/filings/0001437749-26-026427.md) | [5.2](/filings/0001437749-25-033452.md) | [3.1](/filings/0001437749-26-003087.md) | [2.8 d](/filings/0001437749-26-019923.md) | [8.8](/filings/0001437749-26-026427.md) |
| Diluted EPS | $ per share | [1.40](/filings/0001437749-24-033728.md) | [0.64](/filings/0001437749-25-002936.md) | not reported | [2.27](/filings/0001437749-25-025551.md) | [1.47](/filings/0001437749-25-033452.md) | [1.10](/filings/0001437749-26-003087.md) | not reported | [2.16](/filings/0001437749-26-026427.md) | [1.26](/filings/0001437749-25-033452.md) | [0.75](/filings/0001437749-26-003087.md) | not reported | [2.14](/filings/0001437749-26-026427.md) |
| Basic EPS | $ per share | [1.40](/filings/0001437749-24-033728.md) | [0.64](/filings/0001437749-25-002936.md) | not reported | [2.27](/filings/0001437749-25-025551.md) | [1.48](/filings/0001437749-25-033452.md) | [1.10](/filings/0001437749-26-003087.md) | not reported | [2.18](/filings/0001437749-26-026427.md) | [1.27](/filings/0001437749-25-033452.md) | [0.75](/filings/0001437749-26-003087.md) | not reported | [2.16](/filings/0001437749-26-026427.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-09-24) | Q3 FY2023 (2023-12-24) | FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-29) | Q3 FY2024 (2024-12-29) | FY2024 (2025-03-30) | Q1 FY2025 (2025-06-29) | Q2 FY2025 (2025-09-28) | Q3 FY2025 (2025-12-28) | FY2025 (2026-03-29) | Q1 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [37.0](/filings/0001437749-23-029883.md) | [16.7](/filings/0001437749-24-002733.md) | [21.0](/filings/0001437749-25-019916.md) | [26.0](/filings/0001437749-24-025270.md) | [31.2](/filings/0001437749-24-033728.md) | [23.7](/filings/0001437749-25-002936.md) | [27.8](/filings/0001437749-26-019923.md) | [26.9](/filings/0001437749-25-025551.md) | [32.2](/filings/0001437749-25-033452.md) | [24.5](/filings/0001437749-26-003087.md) | [24.4](/filings/0001437749-26-026427.md) | [24.7](/filings/0001437749-26-026427.md) |
| Current assets | $m | [54.5](/filings/0001437749-23-029883.md) | [32.5](/filings/0001437749-24-002733.md) | [38.8](/filings/0001437749-25-019916.md) | [49.0](/filings/0001437749-24-025270.md) | [48.7](/filings/0001437749-24-033728.md) | [40.2](/filings/0001437749-25-002936.md) | [45.1](/filings/0001437749-26-019923.md) | [55.5](/filings/0001437749-25-025551.md) | [55.4](/filings/0001437749-25-033452.md) | [43.9](/filings/0001437749-26-003087.md) | [47.1](/filings/0001437749-26-026427.md) | [58.8](/filings/0001437749-26-026427.md) |
| Total assets | $m | [65.6](/filings/0001437749-23-029883.md) | [42.9](/filings/0001437749-24-002733.md) | [48.9](/filings/0001437749-25-019916.md) | [58.5](/filings/0001437749-24-025270.md) | [57.7](/filings/0001437749-24-033728.md) | [48.7](/filings/0001437749-25-002936.md) | [53.5](/filings/0001437749-26-019923.md) | [63.4](/filings/0001437749-25-025551.md) | [62.9](/filings/0001437749-25-033452.md) | [50.9](/filings/0001437749-26-003087.md) | [53.7](/filings/0001437749-26-026427.md) | [64.8](/filings/0001437749-26-026427.md) |
| Current liabilities | $m | [14.5](/filings/0001437749-23-029883.md) | [11.4](/filings/0001437749-24-002733.md) | [15.6](/filings/0001437749-25-019916.md) | [18.2](/filings/0001437749-24-025270.md) | [16.1](/filings/0001437749-24-033728.md) | [13.7](/filings/0001437749-25-002936.md) | [16.8](/filings/0001437749-26-019923.md) | [20.6](/filings/0001437749-25-025551.md) | [17.7](/filings/0001437749-25-033452.md) | [16.1](/filings/0001437749-26-003087.md) | [18.9](/filings/0001437749-26-026427.md) | [24.0](/filings/0001437749-26-026427.md) |
| Total liabilities | $m | [101](/filings/0001437749-23-029883.md) | [77.9](/filings/0001437749-24-002733.md) | [81.8](/filings/0001437749-25-019916.md) | [84.0](/filings/0001437749-24-025270.md) | [79.0](/filings/0001437749-24-033728.md) | [67.7](/filings/0001437749-25-002936.md) | [70.0](/filings/0001437749-26-019923.md) | [72.8](/filings/0001437749-25-025551.md) | [68.8](/filings/0001437749-25-033452.md) | [66.2](/filings/0001437749-26-003087.md) | [67.9](/filings/0001437749-26-026427.md) | [71.9](/filings/0001437749-26-026427.md) |
| Long-term debt | $m | [79.2](/filings/0001437749-23-029883.md) | [59.5](/filings/0001437749-24-002733.md) | [59.6](/filings/0001437749-25-019916.md) | [59.6](/filings/0001437749-24-025270.md) | [57.2](/filings/0001437749-24-033728.md) | [48.7](/filings/0001437749-25-002936.md) | [48.1](/filings/0001437749-26-019923.md) | [47.5](/filings/0001437749-25-025551.md) | [46.9](/filings/0001437749-25-033452.md) | [46.3](/filings/0001437749-26-003087.md) | [45.7](/filings/0001437749-26-026427.md) | [45.2](/filings/0001437749-26-026427.md) |
| Current portion of debt | $m | not reported | not reported | [0.0](/filings/0001437749-25-019916.md) | not reported | [2.4](/filings/0001437749-24-033728.md) | [2.4](/filings/0001437749-25-002936.md) | [2.4](/filings/0001437749-26-019923.md) | [2.4](/filings/0001437749-25-025551.md) | [2.4](/filings/0001437749-25-033452.md) | [2.4](/filings/0001437749-26-003087.md) | [2.4](/filings/0001437749-26-026427.md) | [2.4](/filings/0001437749-26-026427.md) |
| Shareholders' equity | $m | [(35.4)](/filings/0001437749-25-002936.md) | [(35.0)](/filings/0001437749-25-002936.md) | [(32.9)](/filings/0001437749-26-019923.md) | [(25.5)](/filings/0001437749-25-033452.md) | [(21.3)](/filings/0001437749-26-003087.md) | [(19.0)](/filings/0001437749-26-003087.md) | [(16.5)](/filings/0001437749-26-026427.md) | [(9.3)](/filings/0001437749-26-026427.md) | [(5.9)](/filings/0001437749-26-003087.md) | [(15.3)](/filings/0001437749-26-003087.md) | [(14.2)](/filings/0001437749-26-026427.md) | [(7.2)](/filings/0001437749-26-026427.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-09-24) | Q3 FY2023 (2023-12-24) | Q4 FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-29) | Q3 FY2024 (2024-12-29) | Q4 FY2024 (2025-03-30) | Q1 FY2025 (2025-06-29) | Q2 FY2025 (2025-09-28) | Q3 FY2025 (2025-12-28) | Q4 FY2025 (2026-03-29) | Q1 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [9.2 d](/filings/0001437749-24-033728.md) | [2.2 d](/filings/0001437749-25-002936.md) | [6.4 d](/filings/0001437749-25-019916.md) | [5.0](/filings/0001437749-25-025551.md) | [9.8 d](/filings/0001437749-25-033452.md) | [3.6 d](/filings/0001437749-26-003087.md) | [6.8 d](/filings/0001437749-26-019923.md) | [(0.2)](/filings/0001437749-26-026427.md) | [10.2 d](/filings/0001437749-25-033452.md) | [5.8 d](/filings/0001437749-26-003087.md) | [2.5 d](/filings/0001437749-26-019923.md) | [0.9](/filings/0001437749-26-026427.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001437749-24-033728.md) | [0.1 d](/filings/0001437749-25-002936.md) | [0.1 d](/filings/0001437749-25-019916.md) | [0.0](/filings/0001437749-25-025551.md) | [0.1 d](/filings/0001437749-25-033452.md) | [0.0 d](/filings/0001437749-26-003087.md) | [0.1 d](/filings/0001437749-26-019923.md) | [0.1](/filings/0001437749-26-026427.md) | [0.2 d](/filings/0001437749-25-033452.md) | [0.1 d](/filings/0001437749-26-003087.md) | [0.0 d](/filings/0001437749-26-019923.md) | [0.1](/filings/0001437749-26-026427.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001437749-23-029883.md) | [0.0 d](/filings/0001437749-24-002733.md) | [0.0 d](/filings/0001437749-24-020013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-09-25) | Q3 FY2022 (2022-12-25) | Q1 FY2023 (2023-06-25) | Q2 FY2023 (2023-09-24) | Q3 FY2023 (2023-12-24) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-29) | Q3 FY2024 (2024-12-29) | Q1 FY2025 (2025-06-29) | Q2 FY2025 (2025-09-28) | Q3 FY2025 (2025-12-28) | Q1 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,083](/filings/0001437749-23-029883.md) | [4,116](/filings/0001437749-24-002733.md) | [4,088](/filings/0001437749-24-025270.md) | [4,092](/filings/0001437749-24-033728.md) | [4,080](/filings/0001437749-25-002936.md) | [4,089](/filings/0001437749-25-025551.md) | [4,095](/filings/0001437749-25-033452.md) | [4,093](/filings/0001437749-26-003087.md) | [4,124](/filings/0001437749-26-026427.md) | [4,130](/filings/0001437749-25-033452.md) | [4,119](/filings/0001437749-26-003087.md) | [4,129](/filings/0001437749-26-026427.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,097,661 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026427.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.